CLINICAL_TRIALS
trial_result
· 2021-08-26
Clinical Trial Update: A Phase 2 Study of Lamivudine in Patients With p53 Mutant Metastatic Colorectal Cancer [Phase 2]
Summary
A Phase 2 trial evaluating lamivudine in patients with p53-mutant metastatic colorectal cancer has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2021-08-26